Dow Up0.82% Nasdaq Up0.70%

Arbutus Biopharma Corporation (ABUS)

-NasdaqCM
4.20 Up 0.14(3.45%) May 25, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
Total Revenue 603   12,686   4,065   3,440  
Cost of Revenue -   -   -   -  
Gross Profit 603   12,686   4,065   3,440  
Operating Expenses
Research Development13,144  14,904  16,354  9,690  
Selling General and Administrative7,219  8,354  7,706  7,662  
Non Recurring -  1,017  37,990  361  
Others217  169  153  147  
Total Operating Expenses -  24,444  62,203  17,860  
Operating Income or Loss (19,977) (11,758) (58,138) (14,420)
Income from Continuing Operations
Total Other Income/Expenses Net4,103  5,505  13,960  (466)
Earnings Before Interest And Taxes(15,874)(6,253)(44,178)(14,886)
Interest Expense -   -   -   -  
Income Before Tax(15,874)(6,253)(44,178)(14,886)
Income Tax Expense -  (989)(15,196) -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(15,874)(5,264)(28,982)(14,886)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (15,874) (5,264) (28,982) (14,886)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (15,874) (5,264) (28,982) (14,886)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.